Microbix Biosystems Inc. announced execution of an agreement to return Kinlytic urokinase to market, initially for dissolving blood clots in venous catheters in the United States and to be followed. | May 17, 2023
Kinlytic® urokinase to be developed for re-entry into U.S. marketMISSISSAUGA, Ontario, May 16, 2023 Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter,. | May 16, 2023
Kinlytic® urokinase to be developed for re-entry into U.S. market MISSISSAUGA, CANADA, May 16, 2023 - Microbix Biosystems Inc. , a life sciences innovator,. | May 16, 2023